Potential for Adverse Events in Patients with Generalized Anxiety Disorder
暂无分享，去创建一个
[1] N. Cutler,et al. Placebo Response in Anxiety Disorders , 1996, The Annals of pharmacotherapy.
[2] K. Rickels,et al. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam. , 1993, Archives of general psychiatry.
[3] N. Cutler,et al. Adverse events in placebo‐treated patients with generalized anxiety disorder , 1997, Depression and anxiety.
[4] J. Feighner,et al. A placebo‐controlled double‐blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder , 1993, International clinical psychopharmacology.
[5] S. Woods,et al. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder. , 1992, Advances in biochemical psychopharmacology.
[6] B. Diamond,et al. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety. , 1991, Psychopharmacology bulletin.
[7] B. Diamond,et al. Efficacy and safety of a putative anxiolytic agent: ipsapirone. , 1990, Psychopharmacology bulletin.